[ad_1]
At a time when the entire world continues to suffer from the emerging corona virus, experts are racing against time to discover a treatment and vaccine against the enemy of humanity that has so far infected more than 50 million people and killed more than a million, since it first appeared less than a year ago in China.
What’s new today is a study by the University of Oxford, which announced that aspirin is the latest drug to be evaluated in a large-scale recovery trial and uncovered the use of the common corticosteroid drug “dexamethasone” in treating Covid-19 cases. 19, according to Politico.
According to a press release published Nov. 6, the blood-thinning properties of aspirin, a 120-year-old drug available to everyone, can help prevent complications from blood clots associated with Covid-19.
To that, daily medicine joins the list of more advanced treatments, such as Regeneron’s monoclonal antibodies, which have been analyzed by scientists in the UK as possible treatments for Corona infection.
“The fact that the drug is safe, inexpensive and widely available adds to its appeal,” said Peter Horby of the University of Oxford, the lead investigator involved in the trial. “We are looking for Covid-19 drugs that anyone can immediately use with any type.” A place in the world ”, he points out:“ We don’t know if aspirin is such a drug, but we will find out ”.
It is noteworthy that the study will primarily analyze patient deaths after 28 days, while assessing the length of hospital stay and the need for artificial respiration. According to the version published by the researchers, at least 2,000 infected patients are expected to receive aspirin with their usual care.
It is also likely that it will take several months before a trial produces enough data to judge whether aspirin is beneficial for patients.
Corona is reported to have infected 50,255,095 people so far and killed 1,256,123 worldwide.
[ad_2]
